The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A key role for orexin in panic anxiety
Open accessAbstract
Panic disorder is a severe anxiety disorder with recurrent, debilitating panic attacks. In individuals with panic disorder there is evidence of decreased central γ-aminobutyric acid (GABA) activity as well as marked increases in autonomic and respiratory responses after intravenous infusions of hypertonic sodium lactate. In a rat model of panic disorder, chronic inhibition of GABA synthesis in the dorsomedial-perifornical hypothalamus of rats produces anxiety-like states and a similar vulnerability to sodium lactate–induced cardioexcitatory responses. The dorsomedial-perifornical hypothalamus is enriched in neurons containing orexin (ORX, also known as hypocretin), which have a crucial role in arousal, vigilance and central autonomic mobilization, all of which are key components of panic. Here we show that activation of ORX-synthesizing neurons is necessary for developing a panic-prone state in the rat panic model, and either silencing of the hypothalamic gene encoding ORX (Hcrt) with RNAi or systemic ORX-1 receptor antagonists blocks the panic responses. Moreover, we show that human subjects with panic anxiety have elevated levels of ORX in the cerebrospinal fluid compared to subjects without panic anxiety. Taken together, our results suggest that the ORX system may be involved in the pathophysiology of panic anxiety and that ORX antagonists constitute a potential new treatment strategy for panic disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Sakurai, T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2092 · Cited by 1,276
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Brisbare-Roch, C., Dingemanse, J., Koberstein, R., Hoever, P., Aissaoui, H., Flores, S., Mueller, C., Nayler, O., van Gerven, J., de Haas, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1544 · Cited by 573
Orexin (Hypocretin) Neurons Contain Dynorphin
Chou, T. C., Lee, C. E., Lu, J., Elmquist, J. K., Hara, J., Willie, J. T., Beuckmann, C. T., Chemelli, R. M., Sakurai, T., Yanagisawa, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-j0003.2001 · Cited by 429
Defensive burying in rodents: ethology, neurobiology and psychopharmacology
De Boer, S. F., & Koolhaas, J. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01278-0 · Cited by 389
Attenuated defense response and low basal blood pressure in orexin knockout mice
Kayaba, Y., Nakamura, A., Kasuya, Y., Ohuchi, T., Yanagisawa, M., Komuro, I., Fukuda, Y., & Kuwaki, T. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00671.2002 · Cited by 337
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects
Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., et al. (2009) · Science · doi:10.1126/science.1175055 · Cited by 328
Salomon, R. M., Ripley, B., Kennedy, J. S., Johnson, B., Schmidt, D., Zeitzer, J. M., Nishino, S., & Mignot, E. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01740-7 · Cited by 285
Goddard, A. W., Mason, G. F., Almai, A., Rothman, D. L., Behar, K. L., Petroff, O. A. C., Charney, D. S., & Krystal, J. H. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.556 · Cited by 255
Self-citationRoy-Byrne, P. P., Craske, M. G., & Stein, M. B. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69418-x · Cited by 245
Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.4.547 · Cited by 226
Baseline and fear-potentiated startle in panic disorder patients
Grillon, C., Ameli, R., Goddard, A., Woods, S. W., & Davis, M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90040-x · Cited by 212
Self-citationReduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder
Brundin, L., Björkqvist, M., Petersén, Å., & Träskman-Bendz, L. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.01.005 · Cited by 212
Self-citationThe orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function
Ferguson, A. V., & Samson, W. K. (2003) · Frontiers in Neuroendocrinology · doi:10.1016/s0091-3022(03)00028-1 · Cited by 173
Boshuisen, M. L., Ter Horst, G. J., Paans, A. M. J., Reinders, A. A. T. S., & den Boer, J. A. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01355-0 · Cited by 167
Prepulse inhibition deficits in patients with panic disorder
Ludewig, S., Ludewig, K., Geyer, M. A., Hell, D., & Vollenweider, F. X. (2002) · Depression and Anxiety · doi:10.1002/da.10026 · Cited by 157
The Amygdala, Panic Disorder, and Cardiovascular Responses
Shekhar, A., Sajdyk, T. J., Gehlert, D. R., & Rainnie, D. G. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07090.x · Cited by 139
Self-citationImpaired GABA Neuronal Response to Acute Benzodiazepine Administration in Panic Disorder
Goddard, A. W., Mason, G. F., Appel, M., Rothman, D. L., Gueorguieva, R. V., Behar, K. L., & Krystal, J. H. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2186 · Cited by 121
Self-citationShekhar, A., & Keim, S. R. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00215-4 · Cited by 118
Self-citationShekhar, A., Keim, S. R., Simon, J. R., & McBride, W. J. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00077-9 · Cited by 101
Self-citationCBT Intensity and Outcome for Panic Disorder in a Primary Care Setting
Craske, M. G., Roy-Byrne, P., Stein, M. B., Sullivan, G., Hazlett-Stevens, H., Bystritsky, A., & Sherbourne, C. (2006) · Behavior Therapy · doi:10.1016/j.beth.2005.05.003 · Cited by 94
Samuels, B. C., Zaretsky, D. V., & DiMicco, J. A. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00667.2003 · Cited by 93
Possible mechanisms for lactate's induction of panic
Liebowitz, M. R., Gorman, J. M., Fyer, A., Dillon, D. J., Levitt, M., & Klein, D. F. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.4.495 · Cited by 93
Alprazolam in the Treatment of Panic Disorders
Liebowitz, M. R., Fyer, A. J., Gorman, J. M., Campeas, R. B., Levin, A. P., DAVIES, S. R., Goetz, D. M., & Klein, D. F. (1986) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198602000-00004 · Cited by 92
Johnson, P. L., & Shekhar, A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0408-06.2006 · Cited by 90
Self-citationShekhar, A., & Keim, S. R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09726.1997 · Cited by 90
Self-citationNeural Pathways Underlying Lactate-Induced Panic
Johnson, P. L., Truitt, W. A., Fitz, S. D., Lowry, C. A., & Shekhar, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301621 · Cited by 78
Self-citationShekhar, A., Johnson, P. L., Sajdyk, T. J., Fitz, S. D., Keim, S. R., Kelley, P. E., Gehlert, D. R., & DiMicco, J. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2491-06.2006 · Cited by 77
Self-citationISHII, Y., Blundell, J. E., Halford, J. C. G., Upton, N., Porter, R. A., Johns, A., Jeffrey, P. D., Summerfield, S. G., & Rodgers, R. J. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.07.012 · Cited by 65
The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis
Andreatini, R., Blanchard, C., Blanchard, R. J., Brandão, M. L., Carobrez, A. P., Griebel, G., Guimarães, F. S., Handley, S. L., Jenck, F., Leite, J. R., et al. (2001) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2001000200001 · Cited by 26
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder
Cowley, D. S., Dager, S. R., Roy‐Byrne, P., Avery, D. H., & Dünner, D. L. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90069-x · Cited by 25
Cited by
Control of sleep and wakefulness
Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E., & McCarley, R. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00032.2011 · Cited by 1,477
Sex differences in anxiety and emotional behavior
Donner, N. C., & Lowry, C. A. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1271-7 · Cited by 379
Placing the paraventricular nucleus of the thalamus within the brain circuits that control behavior
Kirouac, G. J. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.005 · Cited by 357
Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour
Bonnavion, P., Mickelsen, L. E., Fujita, A., de Lecea, L., & Jackson, A. C. (2016) · The Journal of Physiology · doi:10.1113/jp271946 · Cited by 271
Circadian and wakefulness-sleep modulation of cognition in humans
Wright, K. P., Lowry, C. A., & LeBourgeois, M. K. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00050 · Cited by 209
Metadata
- Authors
- Johnson, P. L., Truitt, W., Fitz, S. D., Minick, P. E., Dietrich, A., Sanghani, S., Träskman-Bendz, L., Goddard, A. W., Brundin, L., & Shekhar, A.
- Venue
- Nature Medicine
- Published
- 2009-12-27
- Volume
- 16
- Issue
- 1
- Pages
- 111-115
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2049637545
- Cited by
- 414
- References
- 32
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.